GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,429,000 | +34.7% | 32,823 | +34.8% | 0.10% | +61.0% |
| Q1 2022 | $1,061,000 | +16.5% | 24,354 | +17.9% | 0.06% | +22.9% |
| Q4 2021 | $911,000 | +78.3% | 20,653 | +54.5% | 0.05% | +60.0% |
| Q3 2021 | $511,000 | +33.1% | 13,371 | +38.6% | 0.03% | +30.4% |
| Q2 2021 | $384,000 | +73.8% | 9,649 | +55.7% | 0.02% | +53.3% |
| Q1 2021 | $221,000 | -11.6% | 6,198 | -8.8% | 0.02% | -21.1% |
| Q4 2020 | $250,000 | -2.7% | 6,793 | -0.6% | 0.02% | -13.6% |
| Q3 2020 | $257,000 | -0.4% | 6,831 | +8.0% | 0.02% | -12.0% |
| Q2 2020 | $258,000 | +18.3% | 6,323 | +9.9% | 0.02% | -16.7% |
| Q1 2020 | $218,000 | -25.9% | 5,754 | -8.2% | 0.03% | -3.2% |
| Q4 2019 | $294,000 | +26.2% | 6,265 | +15.0% | 0.03% | 0.0% |
| Q3 2019 | $233,000 | -15.6% | 5,449 | -22.9% | 0.03% | -55.7% |
| Q1 2018 | $276,000 | – | 7,071 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |